# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Following a lackluster big bank earnings, market participants now turn their attention to the unfolding week, expecting the tre...
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stori...
Explore the €6 billion financing effort by banks for Sanofi's consumer health division sale. Discover the latest in high-st...
Bank earnings are important not just for the implication for the stocks of these companies but they also are seen as indicator ...
UBS analyst Brennan Hawken maintains Morgan Stanley (NYSE:MS) with a Neutral and raises the price target from $100 to $105.
The U.S. Federal Reserve is considering a rule revision that could save major banks billions in capital. This change targets th...